XS
NVAX icon

XR Securities’s Novavax NVAX Stock Holding History

XR Securities’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,300
Closed -$99.1K – 442
2023
Q1 		$99.1K Buy
+14,300
New +$132K ﹤0.01% 394
2022
Q1 		– Sell
-12,600
Closed -$101K – 456
2021
Q4 		$101K Buy
12,600
+2,800
+29% +$481K 0.01% 280
2021
Q3 		$277K Buy
9,800
+3,200
+48% +$705K 0.13% 151
2021
Q2 		$276K Buy
+6,600
New +$1.21M 0.12% 149

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

XR Securities's NVAX Position: Q1 2022 in Review

XR Securities sold out of Novavax (NVAX) in Q1 2022, closing a stake of 4,199 shares — an estimated $601K sold.

XR Securities first reported a position in NVAX in Q3 2020 and held it in 4 quarters. The position peaked at $601K in Q4 2021. 381 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

  • XR Securities reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
  • XR Securities sold 4,199 Novavax shares in Q1 2022, an estimated $601K.
  • XR Securities first reported a position in Novavax in Q3 2020 and held it in 4 quarters.
  • XR Securities's Novavax position peaked at $601K in Q4 2021.
  • 381 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on XR Securities's 13F filing for Q1 2022, filed 14 Apr 2022.